Outcome of elexacaftor/tezacaftor/ivacaftor therapy in patients with cystic fibrosis and solid organ transplantation
Research output: Contribution to journal › Letter › Research › peer-review
We report a case series of four patients with cystic fibrosis (CF) and previous solid organ transplantation (SOT) receiving elexacaftor/tezacaftor/ivacaftor therapy for 6 months or more. Data was collected retrospectively. The treatment was well tolerated and all patients reported subjective improvements.
| Original language | English |
|---|---|
| Journal | Pediatric Pulmonology |
| Volume | 58 |
| Issue number | 2 |
| Pages (from-to) | 602-605 |
| Number of pages | 4 |
| ISSN | 8755-6863 |
| DOIs | |
| Publication status | Published - 2023 |
Bibliographical note
Publisher Copyright:
© 2022 Wiley Periodicals LLC.
- CFTR therapy, cystic fibrosis, cystic fibrosis transmembrane conductance regulator therapy, ETI, solid organ transplantation
Research areas
ID: 340536792